{"url_path":"/sec/chrs/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings****","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1512762/0001104659-26-058703-index.html","accession_number":"0001104659-26-058703","cik":"0001512762","ticker":"CHRS","issuer_name":"Coherus Oncology, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1512762/0001104659-26-058703-index.html","primary_entity_key":"0001512762","primary_entity_name":"Coherus Oncology, Inc."},"word_count":49,"has_tables":true,"body_markdown":"ITEM 1.              Legal Proceedings****\n\nThe information called for by this Item is incorporated herein by reference to the information set forth in Note 9. Commitments and Contingencies in the Notes to Condensed Consolidated Financial Statements contained in Part I, Item 1 of this Quarterly Report on Form 10-Q.\n\n​"}